Dr. Lal PathLabs Limited

NSEI:LALPATHLAB Rapport sur les actions

Capitalisation boursière : ₹278.4b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Dr. Lal PathLabs Dividende

Dividende contrôle des critères 3/6

Dr. Lal PathLabs est une société versant des dividendes avec un rendement actuel de 0.36% qui est bien couvert par les bénéfices.

Informations clés

0.4%

Rendement du dividende

52%

Ratio de distribution

Rendement moyen de l'industrie0.3%
Prochaine date de paiement du dividenden/a
Date ex-dividenden/a
Dividende par action₹12.000
Résultat par action₹45.80
Prévisions de rendement du dividende à 3 ans0.9%

Mises à jour récentes des dividendes

Recent updates

These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely

Jul 28
These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely

We Think Dr. Lal PathLabs' (NSE:LALPATHLAB) Profit Is Only A Baseline For What They Can Achieve

May 21
We Think Dr. Lal PathLabs' (NSE:LALPATHLAB) Profit Is Only A Baseline For What They Can Achieve

What Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) P/E Is Not Telling You

May 01
What Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) P/E Is Not Telling You

Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

Apr 13
Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely

Mar 06
These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely

Dr. Lal PathLabs Limited Just Missed EPS By 5.4%: Here's What Analysts Think Will Happen Next

Feb 04
Dr. Lal PathLabs Limited Just Missed EPS By 5.4%: Here's What Analysts Think Will Happen Next

Subdued Growth No Barrier To Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Price

Dec 28
Subdued Growth No Barrier To Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Price

Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?

Nov 17
Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?

Dr. Lal PathLabs (NSE:LALPATHLAB) Will Be Hoping To Turn Its Returns On Capital Around

Oct 12
Dr. Lal PathLabs (NSE:LALPATHLAB) Will Be Hoping To Turn Its Returns On Capital Around

Here's Why Dr. Lal PathLabs (NSE:LALPATHLAB) Can Manage Its Debt Responsibly

Jul 07
Here's Why Dr. Lal PathLabs (NSE:LALPATHLAB) Can Manage Its Debt Responsibly

Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

Jun 10
Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

Dr. Lal PathLabs (NSE:LALPATHLAB) Could Be Struggling To Allocate Capital

Feb 13
Dr. Lal PathLabs (NSE:LALPATHLAB) Could Be Struggling To Allocate Capital

Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?

Dec 29
Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?

Dr. Lal PathLabs (NSE:LALPATHLAB) Will Want To Turn Around Its Return Trends

Sep 21
Dr. Lal PathLabs (NSE:LALPATHLAB) Will Want To Turn Around Its Return Trends

These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Reasonably Well

Sep 01
These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Reasonably Well

Dr. Lal PathLabs (NSE:LALPATHLAB) Will Pay A Dividend Of ₹6.00

Jul 31
Dr. Lal PathLabs (NSE:LALPATHLAB) Will Pay A Dividend Of ₹6.00

Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

Jun 23
Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

Does This Valuation Of Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Imply Investors Are Overpaying?

Jun 11
Does This Valuation Of Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Imply Investors Are Overpaying?

These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely

May 25
These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely

Do Dr. Lal PathLabs's (NSE:LALPATHLAB) Earnings Warrant Your Attention?

Apr 28
Do Dr. Lal PathLabs's (NSE:LALPATHLAB) Earnings Warrant Your Attention?

Stabilité et croissance des paiements

Récupération des données sur les dividendes

Dividende stable: LALPATHLAB verse un dividende depuis moins de 10 ans et pendant cette période, les paiements ont été volatils.

Dividende croissant: Les paiements de dividendes de LALPATHLAB ont augmenté, mais la société n'a versé de dividendes que pendant 8 ans.


Rendement des dividendes par rapport au marché

Dr. Lal PathLabs Rendement des dividendes par rapport au marché
Comment le rendement du dividende de LALPATHLAB se compare-t-il à celui du marché ?
SegmentRendement du dividende
Entreprise (LALPATHLAB)0.4%
25% du marché (IN)0.2%
25% du marché (IN)1.1%
Moyenne du secteur (Healthcare)0.3%
Prévisions des analystes dans 3 ans (LALPATHLAB)0.9%

Dividende notable: Le dividende de LALPATHLAB ( 0.36% ) est supérieur à celui des 25 % des payeurs de dividendes les plus faibles du marché Indian ( 0.25% ).

Dividende élevé: Le dividende de LALPATHLAB ( 0.36% ) est faible par rapport aux 25 % des premiers payeurs de dividendes du marché Indian ( 1.08% ).


Bénéfice distribué aux actionnaires

Couverture des revenus: Avec son ratio de distribution raisonnable ( 52.3% ), les paiements de dividendes de LALPATHLAB sont couverts par les bénéfices.


Paiement en espèces aux actionnaires

Couverture des flux de trésorerie: Avec son faible taux de distribution de dividendes ( 20.9% ), les paiements de dividendes de LALPATHLAB sont bien couverts par les flux de trésorerie.


Découvrir des entreprises qui versent des dividendes élevés